Delivery Order SPE2DR25D3501-SPE2DR26FL9FX
- Not listed
- The Defense Logistics Agency (DLA) awarded a $31,949.98 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $14,575.89 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on November 24, 2025, with completion expected by November 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $15,872.15 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count) with a ceiling value of $33,971.19. The contract is scheduled for completion by December 30, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $14,695.34 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). This firm fixed-price, competitively awarded contract was executed on October 24, 2025, with an ultimate completion date of October 27, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,330.33 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) with a contract ceiling value of $7,416.21. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,327.38 for NURTEC ODT 75 MG tablets (8-count) on December 17, 2025, with completion scheduled for December 18, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a Delivery Order valued at $8,406.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This competitively awarded, firm fixed-price contract was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9FXDelivery Order
The Defense Logistics Agency awarded a $4,994.46 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price contract, which is a child order under AmerisourceBergen's larger indefinite delivery contract with DLA, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of November 25, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and healthcare procurement. The company holds a significant $999,999,999 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which provides a comprehensive global pharmaceutical support vehicle for supplying medications, vaccines, and medical supplies to military healthcare systems worldwide. This delivery order falls within that broader contract framework, enabling the company to support Defense Health Agency and other federal healthcare customers with specialty pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/23/25 |